DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Apokyn (Apomorphine Hydrochloride) - Current Clinical Trials

 
 



Apokyn Related Clinical Trials

Apokyn for Motor IMProvement of Morning AKinesia Trial (AM IMPAKT) [Completed]

Treatment of Apomorphine-induced Skin Reactions: a Pilot Study [Not yet recruiting]

Infusion of Apomorphine: Long-term Safety Study [Recruiting]

Safety/Efficacy of Tigan� to Control Nausea/Vomiting Experienced During Apokyn� Initiation and Treatment [Completed]

Relationship Between D2 Receptors SPECT and the Apomorphine Test in Patients With OH Dependence (ALC-DRD2-APO) [Recruiting]

Apomorphine Effects on Experimental Pain [Completed]

Clinical Trial of Apomorphine Subcutaneous Infusion in Patients With Advanced Parkinson's Disease [Recruiting]

Single-Centre Study of VR040(Inhaled Apomorphine) in Idiopathic Parkinson's Disease [Completed]

Efficacy of Continuous Apomorphine Infusion on Cognitive and Neuropsychological Functions in Parkinson's Disease [Recruiting]

Continued Efficacy and Safety of Apomorphine in Patients With Late-Stage Parkinsons Disease [Completed]

Apomorphine Effect on Nociceptive Perception in Parkinson's: a Clinical and Imaging Study [Completed]

Continued Efficacy of Apomorphine After Previous Exposure of at Least Three Months [Completed]

Low Dose Apomorphine and Parkinsonism [Completed]

Blinking and Yawning in Epilepsy: The Role of Dopamine [Active, not recruiting]

Phase 2 Clinical Study of KW-6500 in Parkinson's Disease Patients With Motor Response Complication on Levodopa Therapy [Completed]

Apomorphine Nasal Powder in the Treatment of Parkinson's Disease "Off" Periods. [Not yet recruiting]

Phase IIa Multicentre Study Investigating of VR040 in Parkinson's Disease [Completed]

Efficacy Study of NH001 in Vegetative State & Minimally Conscious State Following a Traumatic Brain Injury [Suspended]

Evaluation of the Role of the Noradrenergic System in Pain Perception in Parkinson's Disease [Recruiting]

JP-1730 to Treat Parkinson's Disease [Completed]

MOTION, Safinamide in Early IPD, as add-on to Dopamine Agonist [Completed]

PET Scanning of Adults With Attention Deficit Hyperactivity Disorder (ADHD) [Completed]

A Phase 3 Study to Examine the Efficacy, Safety and Tolerability of APL-130277 for the Acute Treatment of OFF Episodes in Patients With Parkinson's Disease [Recruiting]

A Study to Examine APL-130277 in Patients With Parkinson's Disease [Completed]

Extended Long-Term Safety Study of KW-6500 [Completed]

Placebo-Controlled Double-Blind Crossover Comparative Study of KW-6500 [Completed]

Long-Term Safety Study of KW-6500 in Patients With Parkinson's Disease [Completed]

EMD 128130 for the Treatment of Parkinson's Disease [Completed]

Efficacy of Caffeine, With and Without Biperiden, in the Detoxification of Cocaine Dependent Patients [Completed]

Exendin-4 as a Treatment for Parkinson's Disease - Pilot Study [Active, not recruiting]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017